Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Frontiers in Microbiology
|
January 9, 2019
Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by <i>A. baumannii</i>
Laura Fernandez-Garcia, Antón Ambroa, Lucia Blasco, et al.
Microorganisms
|
November 16, 2019
Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant <i>Acinetobacter baumannii</i>
Lucia Blasco, Anton Ambroa, Maria Lopez, et al.
Scientific Reports
|
April 30, 2020
In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens
Lucia Blasco, Anton Ambroa, Rocio Trastoy, et al.
Antiviral Therapy
|
October 26, 2011
Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients
Isabel Ruiz-Camps, Oscar Len, Rafael de la Cámara, et al.
Antimicrobial Agents and Chemotherapy
|
January 10, 2025
Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors
Michelle Outeda-García, Jorge Arca-Suárez, Emilio Lence, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2016
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
Belén Gutiérrez-Gutiérrez, Robert A Bonomo, Yehuda Carmeli, et al.
Infection Control and Hospital Epidemiology
|
April 6, 2018
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Oded Scheuerman, Vered Schechner, Yehuda Carmeli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Esther Calbo, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2016
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Belén Gutiérrez-Gutiérrez, Salvador Pérez-Galera, Elena Salamanca, et al.
The Journal of Antimicrobial Chemotherapy
|
January 8, 2017
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Marina De Cueto, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Frontiers in Microbiology
|
January 9, 2019
Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by <i>A. baumannii</i>
Laura Fernandez-Garcia, Antón Ambroa, Lucia Blasco, et al.
Microorganisms
|
November 16, 2019
Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant <i>Acinetobacter baumannii</i>
Lucia Blasco, Anton Ambroa, Maria Lopez, et al.
Scientific Reports
|
April 30, 2020
In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens
Lucia Blasco, Anton Ambroa, Rocio Trastoy, et al.
Antiviral Therapy
|
October 26, 2011
Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients
Isabel Ruiz-Camps, Oscar Len, Rafael de la Cámara, et al.
Antimicrobial Agents and Chemotherapy
|
January 10, 2025
Advancements in the fight against globally distributed OXA-48 carbapenemase: evaluating the new generation of carbapenemase inhibitors
Michelle Outeda-García, Jorge Arca-Suárez, Emilio Lence, et al.
The Journal of Antimicrobial Chemotherapy
|
February 25, 2016
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study
Belén Gutiérrez-Gutiérrez, Robert A Bonomo, Yehuda Carmeli, et al.
Infection Control and Hospital Epidemiology
|
April 6, 2018
Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae
Oded Scheuerman, Vered Schechner, Yehuda Carmeli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Esther Calbo, et al.
Antimicrobial Agents and Chemotherapy
|
May 4, 2016
A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Belén Gutiérrez-Gutiérrez, Salvador Pérez-Galera, Elena Salamanca, et al.
The Journal of Antimicrobial Chemotherapy
|
January 8, 2017
Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae
Zaira Raquel Palacios-Baena, Belén Gutiérrez-Gutiérrez, Marina De Cueto, et al.
Page
of 7